Investigation launched into alleged theft of 30 vials of Sinopharm in Habaraduwa

Friday, 18 June 2021 00:12 -     - {{hitsCtrl.values.hits}}

The Sri Lanka Police has launched an investigation into the alleged theft of 30 vials of the Sinopharm COVID-19 vaccines worth Rs. 90,000 in Habaraduwa.

The investigation was launched after the Habaraduwa Medical Officer of Health lodged a complaint with the Habaraudwa Police, accusing a driver and staff member of stealing the vials.

“The complaint mentions that the 30 vials were stolen since 2 June and the Habaraduwa Officer in Charge has launched an investigation into the matter. A special police team has also been deployed as per the advice of the Galle Senior DIG,” Police Spokesperson DIG Ajith Rohana said.

Health Ministry Spokesperson Dr. Hemantha Herath said that the Southern Province Director of Health Services is also looking into the matter. 

“The Director General of Health Services will issue guidance to all provincial directors of health services and other to prevent such an incident from occurring in future,” Dr. Herath said. According to the Epidemiology Unit, a total of 52,008 persons received the first or second dose of a COVID-19 vaccine on Wednesday and the country’s COVID-19 immunisation program has administered the first dose to 2,380,354 persons and the second dose to 702,551 persons.

According to the Epidemiology Unit, 26,810 persons received the first dose of Sinopharm on Wednesday and 22,501 persons received the second dose of Sinopharm. In total, the first dose of the vaccine has been administered to 1,390,126 persons and the second dose to 339,932 persons.

The second dose of Sputnik V was administered to 2,426 persons on Wednesday and a total of 6,116 persons have received both doses of the vaccine. The first dose of Sputnik V has been administered to 64,986 persons.

The Epidemiology Unit adds that 271 persons received the second dose of AstraZeneca on Wednesday, bringing the total number of persons to receive the second dose of the vaccine to 356,503. The first dose of AstraZeneca has been administered to 925,242 persons.

 

COMMENTS